Fairmount Funds Management’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-469,264
| Closed | -$24.3M | – | 20 |
|
|
2022
Q3 | $24.3M | Hold |
469,264
| – | – | 4.28% | 11 |
|
|
2022
Q2 | $22.2M | Hold |
469,264
| – | – | 5.08% | 10 |
|
|
2022
Q1 | $33.4M | Buy |
469,264
+81,864
| +21% | +$5.83M | 7.9% | 5 |
|
|
2021
Q4 | $29M | Buy |
387,400
+70,448
| +22% | +$5.27M | 9.55% | 3 |
|
|
2021
Q3 | $18M | Buy |
316,952
+138,894
| +78% | +$7.89M | 6.55% | 5 |
|
|
2021
Q2 | $7.84M | Buy |
178,058
+6,911
| +4% | +$304K | 3.22% | 15 |
|
|
2021
Q1 | $8.44M | Buy |
171,147
+20,714
| +14% | +$1.02M | 3.56% | 13 |
|
|
2020
Q4 | $6.33M | Sell |
150,433
-11,803
| -7% | -$497K | 2.27% | 15 |
|
|
2020
Q3 | $7.43M | Sell |
162,236
-7,713
| -5% | -$353K | 3.15% | 12 |
|
|
2020
Q2 | $8.53M | Hold |
169,949
| – | – | 3.81% | 13 |
|
|
2020
Q1 | $8.74M | Buy |
169,949
+8,000
| +5% | +$411K | 5.3% | 10 |
|
|
2019
Q4 | $10M | Buy |
+161,949
| New | +$10M | 6.06% | 8 |
|